Welcome to ATMP Sweden!

'ATMP Sweden' is the national network of Sweden's activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.

Who are we?

CAMP

Driving ATMP technological developments, research translation and manufacturing capabilities.

ATMP Innovation Milieu

Work with us towards making ‘Sweden a world leader in advanced therapies by 2030’

NextGenNK

Competence Center for the development of next generation NK cell-based cancer immunotherapies.

Subscribe to our mailing list

Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.

Follow us on LinkedIn!

RECORDINGS ATMP world tour

View the recorded presentations till June 4th 2021

See the recordings on ’world leading’ ATMP activities, models, partnerships, infrastructures and competencies that are bringing ATMPs to patients around the world!

Read more

News

Inaugural “ATMP world tour” 2021

2021-03-30

Driving International dialogue in cell and gene therapy

Read more

ATMP SWEDEN NEWSLETTER FEBRUARY 2021

2021-02-16

Catch up on the latest including Swedish COVID-19 ATMPs and the ATMP world tour 2021!

Read more

SDP1 permits and standards for cellular ATMPs

2021-02-14

Donors, manufacture, pharmacy and clinic....what permits are needed by who and from whom? What quality standards?

Read more
Display all news

Resources

Commercial aspects resource

Find information, links and support for developing your ATMP commercial model.

The ATMP regulatory guide

Use this guide to navigate development of an ATMP through manufacture and Clinical Trial Application.

Job opportunities

Find or advertise ATMP relevant job opportunities here!

What are ATMPs?

The obvious, less obvious and ATMP related technologies

Did you know that bacteria expressing a human protein can be a ATMP/GTMP? Read more here about what types of treatments/products are classified as ATMPs and which ones are not.

Read more

Events

09

June

Läkemedelsverket Webbinarium ATMP

Seminar

Details

18

November

ATMP Sweden 2021 virtual

Conference

Details
Show all events

Other collaborating national projects

VOG Cell

VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.

AdBIOPRO

AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.

NextGenNK

Sweden are world leader in NK cell research and this group are world leaders in NK cell therapies for patients!

See all ATMP relevant organisations here